Prev Arrow Stocks

Perrigo Company plc ($PRGO) Stock Forecast: Up 5.5% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Perrigo Company plc?

Perrigo Company plc (PRGO) operates in the pharmaceutical sector, focusing on over-the-counter and generic prescription pharmaceuticals, infant formulas, and active pharmaceutical ingredients. Market sentiment is divided because of ongoing legal troubles and class action lawsuits against the company.

Why is Perrigo Company plc going up?

PRGO stock is up 5.5% on Nov 25, 2025 15:10

  • Despite facing various legal challenges, PRGO stock showed a significant upward movement.
  • Investors may be interpreting potential advancements in the legal cases against Perrigo Company plc in a positive light.
  • The stock's bullish trend could also be influenced by market speculations or a change in investor sentiment driven by factors not explicitly mentioned elsewhere.
  • Staying informed about updates on legal proceedings and market dynamics is crucial for making well-informed decisions concerning PRGO stock.

PRGO Price Chart

PRGO Technical Analysis

PRGO News

Bragar Eagel & Squire, P.C. Reminds Stockholders Spirit, Molina, Skye, and Perrigo of the Upcoming Deadlines and Urges Investors to Contact the Firm - Spirit Aviation Holdings ( OTC:FLYYQ ) , Molina Healthcare ( NYSE:MOH )

NEW YORK, Nov. 24, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Spirit Aviation Holdings, Inc. ( OTC:FLYYQ ) , Molina Healthcare, Inc. ( NYSE:MOH ...

https://www.benzinga.com/pressreleases/25/11/g49046639/bragar-eagel-squire-p-c-reminds-stockholders-spirit-molina-skye-and-perrigo-of-the-upcoming-deadli

0 News Article Image Bragar Eagel & Squire, P.C. Reminds Stockholders Spirit, Molina, Skye, and Perrigo of the Upcoming Deadlines and Urges Investors to Contact the Firm - Spirit Aviation Holdings  ( OTC:FLYYQ ) , Molina Healthcare  ( NYSE:MOH )

PRGO Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Perrigo Company plc Class Action - Perrigo ( NYSE:PRGO )

SAN DIEGO, Nov. 20, 2025 ( GLOBE NEWSWIRE ) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Perrigo Company plc ( NYSE:PRGO ) securities between February 27, 2024 and November 4, 2025.

https://www.benzinga.com/pressreleases/25/11/g48986369/prgo-stockholder-notice-shareholder-rights-law-firm-robbins-llp-reminds-investors-of-the-class-act

1 News Article Image PRGO Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Perrigo Company plc Class Action - Perrigo  ( NYSE:PRGO )

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Perrigo Company plc ( NYSE: PRGO ) - Perrigo ( NYSE:PRGO )

NEW YORK, Nov. 19, 2025 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors ( the "Class" ) who purchased or acquired the securities of Perrigo Company plc ( "Perrigo" or the "Company" ) ( NYSE:PRGO ) ...

https://www.benzinga.com/pressreleases/25/11/g48952290/shareholder-alert-bernstein-liebhard-llp-announces-a-securities-fraud-class-action-lawsuit-has-bee

2 News Article Image SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Perrigo Company plc  ( NYSE: PRGO )  - Perrigo  ( NYSE:PRGO )

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Skye Bioscience and Perrigo and Encourages Investors to Contact the Firm - Skye Bioscience ( NASDAQ:SKYE ) , Perrigo ( NYSE:PRGO )

NEW YORK, Nov. 18, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Skye Bioscience, Inc. ( NASDAQ:SKYE ) and Perrigo Company plc ( NYSE:PRGO ) .

https://www.benzinga.com/pressreleases/25/11/g48939659/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-skye-

3 News Article Image Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Skye Bioscience and Perrigo and Encourages Investors to Contact the Firm - Skye Bioscience  ( NASDAQ:SKYE ) , Perrigo  ( NYSE:PRGO )

Perrigo Company plc Price History

28.01.2025 - PRGO Stock was up 15.2%

  • Perrigo (PRGO) outperformed Q4 earnings expectations, delivering positive surprises in both earnings and revenue.
  • Strategic price adjustments likely boosted the company's revenue, positively impacting its overall performance.
  • Investor confidence in Perrigo's financial well-being and future outlook is fueling the current bullish trend in the stock.

28.01.2025 - PRGO Stock was up 18.2%

  • Perrigo's bullish movement today can be attributed to the positive outlook provided in their 2025 growth plans, including projected sales boost and margin expansion by 2027.
  • The Q4 earnings beat estimates, with both earnings and revenue surpassing expectations, indicating strong performance by the company.
  • The focus on improving cash flow and strategic price increases leading to higher net price realization for its products likely contributed to investor confidence in Perrigo's future prospects.
  • The anticipation surrounding Perrigo's Q4 earnings and the overall positive sentiment towards biotech and drug companies releasing their results might have further boosted PRGO's stock performance today.

06.10.2024 - PRGO Stock was up 6.7%

  • Perrigo's Q3 earnings and revenues fell short of estimates, but the stock showed significant upward momentum.
  • Factors such as potential cost reductions, new product advancements, and strategic partnerships may have pleasantly surprised investors.
  • There is a possibility that the market is expecting a turnaround in the company's performance in the coming quarters due to optimistic growth prospects and upcoming catalysts.
  • Investors could be focusing on Perrigo's long-term potential rather than short-term results, fueling the bullish movement in the market.

25.10.2025 - PRGO Stock was up 5.5%

  • Despite facing various legal challenges, PRGO stock showed a significant upward movement.
  • Investors may be interpreting potential advancements in the legal cases against Perrigo Company plc in a positive light.
  • The stock's bullish trend could also be influenced by market speculations or a change in investor sentiment driven by factors not explicitly mentioned elsewhere.
  • Staying informed about updates on legal proceedings and market dynamics is crucial for making well-informed decisions concerning PRGO stock.

05.10.2025 - PRGO Stock was down 21.4%

  • The decline in PRGO stock today may be linked to the revenue results for the quarter ending September 2025, which fell short of estimates by -4.84%.
  • Despite exceeding earnings estimates by +6.67%, the market's negative reaction to the revenue shortfall suggests apprehensions about the company's growth potential.
  • Concerns about PRGO stock's future performance may arise as the revenue miss could signal challenges to the company's financial health and stability.

07.04.2025 - PRGO Stock was up 5.4%

  • Perrigo (PRGO) surpassed expectations with its Q1 earnings, demonstrating a strong performance.
  • Despite challenges predicted from exiting businesses and adverse currency fluctuations, the company outperformed revenue forecasts.
  • The better-than-expected earnings suggest growth potential and resilience against anticipated hurdles, prompting a bullish trend in the stock.
  • Investors may interpret Perrigo's superior performance as a positive indicator for the company's future prospects, fueling the bullish market behavior.

10.03.2025 - PRGO Stock was down 5.6%

  • Perrigo's stock might have experienced a bearish movement due to profit-taking by investors after a recent uptrend.
  • The positive movement in Sanara MedTech's stock could have diverted some investor attention away from Perrigo, leading to a decrease in demand.
  • The lack of strong earnings estimate revisions for Perrigo may have also contributed to the bearish sentiment surrounding the stock.
  • Overall, the combination of market factors and specific company news could have led to the bearish movement in Perrigo's stock today.

07.04.2024 - PRGO Stock was down 7.0%

  • Perrigo beat earnings per share (EPS) estimates but missed revenue expectations for Q1 2024, indicating a mixed performance.
  • The reaffirmation of the company's fiscal 2024 outlook for sales growth might not have been strong enough to offset concerns about revenue miss.
  • The executive transition in the Consumer Self-Care International business could have raised uncertainties among investors about the company's future leadership and strategic direction.
  • The market reaction to the earnings report and executive transition news likely contributed to the bearish movement in PRGO stock today.

06.10.2025 - PRGO Stock was down 8.2%

  • PRGO posted Q3 earnings exceeding expectations but underperformed in sales, resulting in a mixed outcome.
  • Following a downward revision of its 2025 outlook and the initiation of a review of its infant formula unit, investor worries about future growth prospects were sparked, leading to a decline in the stock price.
  • Despite surpassing earnings expectations, PRGO faced a notable bearish movement in the stock market due to negative reactions to the uncertainty surrounding the company's strategic decisions.

02.07.2024 - PRGO Stock was down 4.5%

  • In the second quarter of 2024, Perrigo (PRGO) delivered a mixed performance. While the company surpassed earnings per share (EPS) estimates, it fell short of revenue expectations. This discrepancy in financial results likely influenced the bearish trend in the stock price.
  • Perrigo adjusted its total net sales predictions for the year downwards. This revision was mainly driven by reduced distribution projections in the U.S. store brand segment for the latter part of 2024. The lowered sales forecast might have had a negative impact on investor confidence.
  • Despite outperforming EPS estimates, Perrigo saw a cut in its total net sales growth forecast. This alteration in sales expectations raised concerns about the company's future revenue prospects, potentially amplifying the negative market sentiment surrounding the stock.
  • The significant decrease in earnings compared to the corresponding period last year, as outlined in the Q2 earnings overview, likely played a role in the overall adverse stock movement of Perrigo (PRGO).

19.10.2025 - PRGO Stock was down 5.1%

  • The securities fraud class action lawsuit filed against Perrigo Company plc might have created uncertainty and negative sentiment among investors, leading to a sell-off of PRGO shares.
  • The reminder to investors about the ongoing class action lawsuits against Perrigo Company plc could have further fueled concerns and prompted more selling pressure on the stock.
  • The legal challenges and potential financial implications from the lawsuits may have overshadowed any positive developments or fundamentals related to Perrigo Company plc, contributing to the bearish market movement of PRGO today.

06.07.2025 - PRGO Stock was down 16.1%

  • Perrigo (PRGO) posted earnings and revenue figures for Q2 that fell below expectations, resulting in a decline in the stock price.
  • Despite the disappointing performance, financial analysts are bullish on Perrigo's future, anticipating a potential 36% increase in the stock price.
  • Investors are keeping a close eye on Perrigo's Q2 earnings release to glean insights into its Kairos deal and strategies for navigating macroeconomic pressures that may have contributed to the recent market downturn.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.